Charity or Bribery Custom Case Solution & Analysis

Evidence Brief

Financial Metrics

Contract Value: 10 million RMB for the sale of medical imaging equipment. Source: Paragraph 4.
Donation Request: 1 million RMB to be paid to a foundation affiliated with the hospital. Source: Paragraph 6.
Market Context: China represents a high growth region for the firm with 15 percent year over year increases in revenue. Source: Exhibit 2.
Penalty Risk: Potential fines under the Foreign Corrupt Practices Act can exceed 20 million dollars per violation. Source: Paragraph 12.

Operational Facts

Procurement Process: The hospital uses a closed tender system where the Hospital Director has final approval authority. Source: Paragraph 8.
Compliance Protocol: All charitable donations above 50000 dollars require approval from the Global Compliance Office in the United States. Source: Paragraph 10.
Timing: The contract award decision is scheduled for the end of the current fiscal quarter. Source: Paragraph 5.

Stakeholder Positions

Jiang: Regional Manager who faces pressure to meet annual sales targets but fears legal repercussions. Source: Paragraph 3.
Dr. Chen: Hospital Director who suggested the donation and implied a link between the gift and the contract success. Source: Paragraph 7.
Maria: Global Compliance Officer who maintains a zero tolerance policy for payments that appear to be a quid pro quo. Source: Paragraph 11.

Information Gaps

The legal status and registration details of the hospital foundation are not provided in the case text.
The specific history of previous donations by competitors to this same foundation is absent.
Internal audit reports regarding previous sales at this specific hospital are missing.

Strategic Analysis

Core Strategic Question

How can the company secure the 10 million RMB contract while ensuring absolute compliance with international anti bribery laws and internal ethical standards?
What is the long term impact on the China market strategy if the company refuses to participate in local customary gift giving?

Structural Analysis

The situation involves high bargaining power of the buyer. Dr. Chen controls access to a significant revenue stream. The threat of substitutes is high as competitors may be more willing to fulfill the donation request. However, the regulatory environment is the primary constraint. Under the Foreign Corrupt Practices Act, the intent of the payment matters more than the label of charity. Because the donation is linked to a specific procurement decision, it carries extreme legal risk.

Strategic Options

Option 1: Approve the donation as requested. This secures the revenue but exposes the company and individuals to criminal prosecution and massive fines. The trade off is short term profit versus existential legal risk.

Option 2: Explicitly deny the donation. This protects the company from legal risk but likely results in the loss of the 10 million RMB contract and damages the relationship with a key hospital director. The trade off is ethical integrity versus market share loss.

Option 3: Propose a transparent educational grant. Instead of a foundation payment, offer a direct sponsorship for medical staff training with oversight from the Global Compliance Office. This addresses the stated goal of the foundation while removing the opacity of the payment.

Preliminary Recommendation

The company must pursue Option 2 while attempting to pivot to Option 3. The current request from Dr. Chen is a textbook example of a bribe disguised as a donation. The risk to the global organization far outweighs the value of a single 10 million RMB contract. Jiang should inform Dr. Chen that the company policy prohibits donations during active tender periods but offers separate, transparent support for clinical education through official channels.

Implementation Roadmap

Critical Path

Immediate Action: Jiang must document the conversation with Dr. Chen and report it to the Global Compliance Office within 24 hours.
Communication: Issue a formal letter to the hospital procurement committee stating the commitment of the company to fair competition and transparency.
Alternative Proposal: Submit a proposal for an open medical symposium or training program that is available to all hospital staff, not just those selected by Dr. Chen.
Legal Review: Engage local counsel to verify if the foundation of the hospital has any legal ties to government officials that would trigger mandatory reporting.

Key Constraints

Sales Incentives: The current bonus structure for Jiang encourages high risk behavior to meet targets. This must be adjusted to include compliance milestones.
Cultural Expectations: The local sales team believes that refusing the request is equivalent to exiting the market. Overcoming this internal resistance is a primary hurdle.

Risk Adjusted Implementation Strategy

The strategy assumes the loss of the current contract. To mitigate this, the company should diversify its pipeline across private hospitals where procurement is less dependent on single government officials. Contingency planning includes a full internal audit of all active bids in the region to ensure no other unauthorized promises have been made by the sales staff. Success will be measured by the avoidance of legal discovery rather than the immediate closing of the MRI sale.

Executive Review and BLUF

BLUF

Deny the 1 million RMB donation request immediately. The link between the payment and the 10 million RMB contract creates a clear violation of the Foreign Corrupt Practices Act. The financial gain of the sale is negligible compared to the potential for criminal indictments, debarment from future government contracts, and the destruction of brand equity. The company should prioritize legal safety over quarterly sales targets in the China region. Maintain the relationship through transparent educational initiatives that pass international audit standards. Do not compromise on the code of conduct for short term revenue.

Dangerous Assumption

The most dangerous assumption is that the 1 million RMB payment will actually secure the contract. In corrupt environments, making one payment often leads to secondary and tertiary demands, or the official may accept the money and still award the contract to a competitor who offered more. There is no guarantee of performance on an illicit deal.

Unaddressed Risks

Retaliation Risk: Dr. Chen may use his influence to blacklist the company from other hospitals in the region. This consequence is high in probability and could impact the long term growth of the firm.
Whistleblower Risk: If the payment is made, any disgruntled employee in the regional office could report the violation to the SEC for a reward, ensuring that the bribe is eventually discovered.

Unconsidered Alternative

The team should consider a joint venture with a local partner for distribution. By shifting the sales responsibility to a local entity, the company can distance itself from direct negotiations while maintaining strict compliance requirements in the partnership agreement. This provides a buffer while the firm builds a more transparent direct sales model.